We are live on ! Find out more
VIVO

Meridian Bioscience Inc
VIVO

Delisted

VIVO was delisted on the 30th of January, 2023.

Back to rankings

177 hedge funds and large institutions have $592M invested in Meridian Bioscience Inc in 2018 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 60 increasing their positions, 62 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

684% more call options, than puts

Call options by funds: $1.31M | Put options by funds: $167K

13% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 16

0% more funds holding

Funds holding: 177 → 177 (0)

3% less repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 62

4% less capital invested

Capital invested by funds: $615M → $592M (-$22.8M)

Holders
177
Holders Change
–
Holders Change %
0%
% of All Funds
4.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
60
Reduced
62
Closed
16
Calls
$1.31M
Puts
$167K
Net Calls
+$1.14M
Net Calls Change
-$704K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$5.08M
2
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$4.48M
3
Invesco
Invesco
Georgia
+$4.24M
4
Morgan Stanley
Morgan Stanley
New York
+$2.97M
5
Renaissance Technologies
Renaissance Technologies
New York
+$2.63M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$2.6M
2
Citadel Advisors
Citadel Advisors
Florida
-$2.2M
3
Prudential Financial
Prudential Financial
New Jersey
-$2.05M
4
Deutsche Bank
Deutsche Bank
Germany
-$1.93M
5
CS
Credit Suisse
Switzerland
-$1.58M
Name Holding Trade Value Shares
Change 		Change in
Stake
SBH
26
Segall Bryant & Hamill
Illinois
$4.13M +$1.02M +65,561 +31%
Millennium Management
27
Millennium Management
New York
$4.11M -$2.6M -167,745 -38%
MAM
28
Martingale Asset Management
Massachusetts
$4.07M +$57.4K +3,702 +1%
Deutsche Bank
29
Deutsche Bank
Germany
$4.03M -$1.93M -124,439 -32%
Hotchkis & Wiley Capital Management
30
Hotchkis & Wiley Capital Management
California
$3.44M +$947K +61,099 +36%
OAM
31
Oxford Asset Management
United Kingdom
$3.08M +$564K +36,403 +21%
Two Sigma Advisers
32
Two Sigma Advisers
New York
$3.05M -$839K -54,100 -21%
Goldman Sachs
33
Goldman Sachs
New York
$2.99M -$910K -58,713 -23%
GF
34
Gabelli Funds
New York
$2.86M -$62K -4,000 -2%
Citadel Advisors
35
Citadel Advisors
Florida
$2.7M -$2.2M -141,909 -44%
Arrowstreet Capital
36
Arrowstreet Capital
Massachusetts
$2.62M +$1.65M +106,140 +152%
CIS
37
Connors Investor Services
Pennsylvania
$2.58M -$90.8K -5,859 -3%
GI
38
GAMCO Investors
Connecticut
$2.44M -$124K -8,000 -5%
LSV Asset Management
39
LSV Asset Management
Illinois
$2.24M -$216K -13,900 -8%
MIP
40
Mondrian Investment Partners
United Kingdom
$2.24M – – –
SIM
41
Spark Investment Management
New York
$2.21M – – –
RA
42
Royce & Associates
New York
$2.2M +$11K +709 +0.5%
TA
43
Teton Advisors
New York
$2M -$326K -21,000 -14%
Barrow, Hanley, Mewhinney & Strauss
44
Barrow, Hanley, Mewhinney & Strauss
Texas
$2M -$231K -14,867 -10%
New York State Teachers Retirement System (NYSTRS)
45
New York State Teachers Retirement System (NYSTRS)
New York
$1.94M -$43.1K -2,777 -2%
SCA
46
Secor Capital Advisors
New York
$1.9M -$809K -52,172 -29%
Fifth Third Bancorp
47
Fifth Third Bancorp
Ohio
$1.88M -$6.4K -413 -0.3%
GCP
48
GSA Capital Partners
United Kingdom
$1.86M -$232K -14,955 -11%
Los Angeles Capital Management
49
Los Angeles Capital Management
California
$1.8M +$573K +36,952 +44%
California Public Employees Retirement System
50
California Public Employees Retirement System
California
$1.78M +$514K +33,146 +38%
1
2
3 4 5

VIVO Hedge Fund Activity: Q3 2018 in Review

177 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q3 2018, worth a combined $592M — down 3.7% from $615M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new VIVO positions and 16 closed out — a net gain of 2 holders — while 60 added to existing stakes and 62 trimmed.

The largest buyer was BlackRock, adding an estimated $5.08M. The largest seller was Millennium Management, cutting an estimated $2.6M.

  • 177 institutional investors held Meridian Bioscience Inc (VIVO) as of Q3 2018, unchanged from Q2 2018.
  • Funds reported $592M of Meridian Bioscience Inc stock for Q3 2018, down 3.7% quarter-over-quarter.
  • 18 funds opened new Meridian Bioscience Inc positions in Q3 2018 and 16 closed out, a net change of +2 holders.
  • The largest Meridian Bioscience Inc buyer in Q3 2018 was BlackRock, an estimated $5.08M added.
  • The largest Meridian Bioscience Inc seller in Q3 2018 was Millennium Management, an estimated $2.6M sold.

Based on aggregated 13F filings for Q3 2018.